Mylan Institutional, Inc. (d.b.a. UDL Laboratories) recalls Clonazepam Tablets, USP, 0.5 mg, 100-count carton, Rx only, Manufactured by Mylan Pharmaceuticals Inc., Morgantown, WV,…
- Recall date
- January 28, 2016
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0650-2016
- FDA classification
- Class III
- Brand / firm
- Mylan Institutional, Inc. (d.b.a. UDL Laboratories)
- Sold / distributed
- Nationwide
Why it was recalled
Failed Impurities/Degradation Specifications: out of specification result for known impurity at 6 month timepoint.
Class III means the product violates regulations but is not likely to cause harm.
What was recalled
Clonazepam Tablets, USP, 0.5 mg, 100-count carton, Rx only, Manufactured by Mylan Pharmaceuticals Inc., Morgantown, WV, 26505, NDC:51079-881-21
Get recall alerts
Free email alert whenever Mylan Institutional, Inc. (d.b.a. UDL Laboratories) has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Mylan Institutional, Inc. (d.b.a. UDL Laboratories)